Tutorials
Natus Medical Inc logo

Natus Medical Inc

€ 31.80 (-1.85%) Jul 21
P/E:
89.08
P/B:
2.64
Market Cap:
€ 1.12B ($ 1.14B)
Enterprise V:
€ 1.05B ($ 1.07B)
Volume:
-
Avg Vol (2M):
-
Also Trade In:
Volume:
-
Market Cap €:
1.12B
Market Cap $:
1.14B
PE Ratio:
89.08
Avg Vol (2-Month):
-
Enterprise Value €:
1.05B
Enterprise Value $:
1.07B
PB Ratio:
2.64
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

Natus Medical Inc
NAICS : 334510 SIC : 3845
3150 Pleasant View Road, Middleton, WI, USA, 53562
Compare
Compare
TMDX HSKA PACB KIDS CERS AVNS TMCI VREX BFLY ESTA ABT MDT SYK EW BSX SZSE:300760 DXCM ZBH STE ALGN
Traded in other countries / regions
NM4.Germany NTUS.USA
Description
Natus Medical Inc is a provider of newborn care, neurology, and hearing and balance assessment healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders. It is divided into three business units: Neuro, Newborn Care, and Hearing and Balance. The company generates a majority of its revenue from the Neurology business unit which includes products and services that provide diagnostic, therapeutic and surgical solutions in neurodiagnostics, neurocritical care, and neurosurgery.
Name Current Vs Industry Vs History
Cash-To-Debt 8.23
Equity-to-Asset 0.76
Debt-to-Equity 0.02
Debt-to-EBITDA 0.21
Interest Coverage 24.35
Piotroski F-Score 8/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 6.53
Distress
Grey
Safe
Beneish M-Score -2.58
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 36.13
9-Day RSI 47.27
14-Day RSI 52.12
6-1 Month Momentum % 40.38
12-1 Month Momentum % 41.75

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.54
Quick Ratio 1.9
Cash Ratio 0.75
Days Inventory 123.98
Days Sales Outstanding 75.85
Days Payable 53.39

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.4

Financials (Next Earnings Date:2022-11-04 Est.)

FRA:NM4's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 415.69
EPS (TTM) (€) 0.317
Beta 0
Volatility % 47.32
14-Day RSI 52.12
14-Day ATR (€) 0.69835
20-Day SMA (€) 31.92
12-1 Month Momentum % 41.75
52-Week Range (€) 19 - 32.8
Shares Outstanding (Mil) 34.58

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 8
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Natus Medical Inc Filings

Document Form Filing Date
No Filing Data